Samsung Seoul Hospital Achieves 1,500 Robotic Stomach Cancer Surgeries... 90% Five-Year Relative Survival Rate
22% of Stomach Cancer Surgeries Performed with Robots Last Year
Only Hospital in Korea to Introduce Gastrointestinal-Specialized "Da Vinci 5"
Samsung Seoul Hospital announced on September 2 that it has reached a cumulative total of 1,500 robotic surgeries for stomach cancer.
Samsung Seoul Hospital held a commemorative ceremony on the 28th of last month to celebrate reaching 1,500 cases of robotic stomach cancer surgery. In the front row from the left are Taesung Son, Deputy Director of Medical Services; Jiyoung Ahn, Professor of Gastrointestinal Surgery; Junho Lee, Head of Gastrointestinal Surgery; Jiyeon Lee, Director of the Stomach Cancer Center; Heecheol Kim, Director of the Cancer Hospital; and Sanghoon Ahn, Professor of Gastrointestinal Surgery. Photo by Samsung Seoul Hospital
View original imageAs a result of its continuous expansion of minimally invasive surgeries aimed at reducing patients' pain, bleeding, and scarring, the hospital performed 256 robotic procedures out of the total 1,174 stomach cancer surgeries conducted last year, accounting for 22% of the cases.
The hospital expects the adoption of the latest "Da Vinci 5 (DV5)" robotic surgical system, dedicated solely to the Department of Gastrointestinal Surgery, to further accelerate the expansion of robotic surgeries. Samsung Seoul Hospital is currently the only hospital in Korea to have installed the DV5 exclusively for gastrointestinal surgery.
Junho Lee, Chief of the Department of Gastrointestinal Surgery at Samsung Seoul Hospital, said, "Introducing dedicated robotic equipment will improve surgical techniques that maintain both the treatment outcomes and the quality of life for stomach cancer patients. We will continue to focus on developing surgical methods that deliver even better treatment results for our patients."
Samsung Seoul Hospital forecasted that the growing use of robotic surgery will continue to improve outcomes for stomach cancer treatment. Currently, the five-year relative survival rate for stomach cancer patients at Samsung Seoul Hospital is 89.5%, which is higher than the Korean average of 78.6% and the U.S. average of 37.9%. The 90-day post-operative mortality rate is also just 0.42%, about half the average of 0.98% for tertiary general hospitals.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Jiyeon Lee, Director of the Stomach Cancer Center at Samsung Seoul Hospital (Hematology and Oncology), remarked, "By achieving a cumulative 1,500 robotic stomach cancer surgeries, we have once again demonstrated our global competitiveness. We will continue to pioneer new standards in stomach cancer care through accurate diagnosis and optimal treatment."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.